RCMI Coordinating Center (RCMI CC) Header Logo

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following properties of Serafine, Katherine
PropertyValue
overview Research in Dr. Serafine’s behavioral pharmacology laboratory focuses on the different factors that contribute to individual differences in vulnerability to drug abuse. To investigate these factors, Dr. Serafine uses preclinical models to investigate how factors such as age, sex and diet impact sensitivity to drugs of abuse like cocaine. Drug sensitivity is assessed using behavioral pharmacological models including unconditioned behavior (e.g., locomotion) and more complex behaviors using classical and operant conditioning (e.g., conditioned place preference, drug discrimination, or intravenous self-administration). Students in the laboratory receive hands on training on how to conduct behavioral experiments that help answer important questions about abuse vulnerability. Dr. Serafine’s current research interests include studying how diets high in fat or sugar change individual sensitivity to cocaine and other drugs that act on dopamine systems. Dr. Serafine is also interested in considering differential impact of age, sex and diet on sensitivity to prescription drugs such as antidepressants and drugs used to treat obesity.
Search Criteria
  • Cocaine
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support